Can a Rapid Point-of-Care Biomarker Test Help Physicians Identify Sepsis 72 Hours Earlier?
Sepsis is a medical emergency, and even a 1-hour delay in the diagnosis of sepsis can lead to higher mortality rates, more irreversible and lifelong consequences, and an increased length of hospital stay for patients. There is an important need for a diagnostic tool that can rapidly identify the onset of sepsis and allow for earlier management. Abionic's sepsis test exploits the kinetics of the Pancreatic Stone Protein (PSP) biomarker in blood, to immediately signal whether a patient has sepsis or not, up to 72 hours before the standard of care.
Join Abionic* for this free online webinar on the 22nd of September to discover real-world evidence from 3 European hospitals and how they've implemented the use of PSP measurements to support their everyday activities. Earlier identification of sepsis opens a window of opportunity to improve the treatment and management of the disease.
Follow the registration link below to see the line-up of expert speakers and the internationally renowned Chairman.
*Abionic is a sponsor of World Sepsis Day – you can read our sponsorship guidelines here. The Global Sepsis Alliance was not involved in organizing this webinar.